Contract modification means DOD records can be stored in Cerner data centers

Thanks to a contract modification, military health records can now be stored in Cerner's data centers rather than government data centers.

The federal government awarded the $4.3 billion Department of Defense contract to the Leidos/Cerner/Accenture team to overhaul the military's health records. 

The new contract was posted Dec. 18 on FedBizOpps.gov, a site where federal agencies can post business opportunities and commercial vendors can search for them. The notice was posted by the Space and Naval Warfare Systems Command, which supports the Defense Healthcare Management System Modernization (DHMSM) Program office.

"While [the] Leidos solution meets the contract requirements, many of the capabilities of the DHMSM EHR cannot be fully realized unless they are hosted in the Cerner environment," according to the notice. "In order to fully enable these functionalities, the DHMSM EHR requires direct access to proprietary Cerner data, which is only available within Cerner-owned and operated data centers."

Proprietary Cerner data include models based on clinical, operational and financial data that have been developed by analyzing patient data and information from other Cerner applications. Because of the sources of the data and tools found in the Cerner solution, the notice says no other contractor can provide this functionality. It also explains that the government could not have anticipated this need which is why it wasn't included in the original request for proposals.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.